Results 231 to 240 of about 2,101,293 (251)

Common metabolic, environmental, and molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders. [PDF]

Front Neurol
Vallés AS, Barrantes FJ.
europepmc   +1 more source

Engineered nanomedicine remodels the postoperative cavity microenvironment to suppress glioblastoma recurrence. [PDF]

Theranostics
Bai Z, Chen Z.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L. Siegel, Jill S. Barnholtz-Sloan, Carol Kruchko   +2 more
exaly  

Cholesterol in Brain Development and Perinatal Brain Injury: More than a Building Block

Current Neuropharmacology, 2022
Xiangning Jiang
exaly  

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Marion Smits, Jeffrey Weinberg, James B Yu   +2 more
exaly  

Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease

Journal of Controlled Release, 2021
Flavio Forni, Alice Passoni, Monica Favagrossa   +2 more
exaly  

Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism

Proceedings of the National Academy of Sciences of the United States of America, 2020
Roberto Angelini, Natalia Mast, Irina Pikuleva   +2 more
exaly  

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers

Cancer Cell, 2016
Benjamin Cravatt, David F L Jenkins, Michael L Martini   +2 more
exaly  

Brain Cholesterol: Long Secret Life Behind a Barrier

Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
Ingemar Bjorkhem, Steve Meaney
exaly